Encelo Laboratories
Encelo is a pioneering biotech company founded in 2017, dedicated to revolutionizing urine-derived cell collection and study. Their mission is to advance research, diagnostics, and personalized medicine through innovative technology, including the Cell Catcher device, which improves the recovery and analysis of live cells from urine samples. Supported by notable organizations and recognized for potential, Encelo aims to unlock the full potential of urine-derived cells for medical breakthroughs.
Industries
Nr. of Employees
small (1-50)
Encelo Laboratories
Products
Benchtop urine cell capture and preservation unit (clinic edition)
A standalone benchtop unit for on-site processing of urine samples that separates cells without centrifugation, introduces a preservation medium into a central hub to keep cells alive and in suspension at room temperature, and produces material retrievable for laboratory culture and analysis.
Home urine cell collection kit for remote donor sampling (home edition)
A kit designed for distribution to donors for at-home collection and processing of urine samples by lay users, compatible with overnight mailing to a laboratory while preserving viable cells for at least 24 hours.
Benchtop urine cell capture and preservation unit (clinic edition)
A standalone benchtop unit for on-site processing of urine samples that separates cells without centrifugation, introduces a preservation medium into a central hub to keep cells alive and in suspension at room temperature, and produces material retrievable for laboratory culture and analysis.
Home urine cell collection kit for remote donor sampling (home edition)
A kit designed for distribution to donors for at-home collection and processing of urine samples by lay users, compatible with overnight mailing to a laboratory while preserving viable cells for at least 24 hours.
Services
Service to generate genetically diverse libraries of primary cells or iPSC from specified patient populations, using proprietary processing and medium formulation to improve success rates.
Laboratory processing service for captured urine-derived cells including retrieval, plating and preparation for downstream analysis.
Service to generate genetically diverse libraries of primary cells or iPSC from specified patient populations, using proprietary processing and medium formulation to improve success rates.
Laboratory processing service for captured urine-derived cells including retrieval, plating and preparation for downstream analysis.
Expertise Areas
- Urine-derived primary cell collection and preservation
- Virtual biobanking and patient-derived cell library generation
- Remote patient sampling and sample logistics for biological material
- Benchtop point-of-care sample processing device development
Key Technologies
- Urine-derived primary cell capture
- Ambient-temperature cell preservation medium
- Benchtop point-of-care sample processing device
- Remote/home biological sample collection kits
News & Updates
Encelo was selected as a start-up with the most potential at the Beanstalks competition at Giant Health exhibition, London, 2021.
Interview with Encelo's CEO Dr. Katia Nazmutdinova on how simplicity can solve complex problems, by Teresa Murray for Healthtech and Giant Health co Conference.
Results of the clinical validation of the Cell Catcher (beta), showcased at the Otto Wolf Symposium, UCL Great Ormond Street Hospital.
Encelo was recognized as a promising start-up at the Giant Health exhibition in London, 2021.
An interview with CEO Dr. Katia Nazmutdinova on how simplicity can address complex challenges.
Clinical validation results of the Cell Catcher device, presented at a symposium.
Encelo was selected as a start-up with the most potential at the Beanstalks competition at Giant Health exhibition, London, 2021.
Interview with Encelo's CEO Dr. Katia Nazmutdinova on how simplicity can solve complex problems, by Teresa Murray for Healthtech and Giant Health co Conference.
Results of the clinical validation of the Cell Catcher (beta), showcased at the Otto Wolf Symposium, UCL Great Ormond Street Hospital.
Encelo was recognized as a promising start-up at the Giant Health exhibition in London, 2021.
An interview with CEO Dr. Katia Nazmutdinova on how simplicity can address complex challenges.
Clinical validation results of the Cell Catcher device, presented at a symposium.